A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
Clinical trial NCT00606177 · COMPLETED
Trial details
- NCT number
- NCT00606177
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-11-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.